Clinical Manifestations.

Area of Science:

• Neuroscience
• Audiology
• Cognitive Science

Background:

• Auditory scene analysis difficulties are an early indicator of Alzheimer's disease.
• Existing speech-based tests are limited by language and cultural variations.
• A novel non-verbal dichotic listening test (NVDLT) is introduced to overcome these limitations.

Purpose of the Study:

• To introduce and validate a new non-verbal dichotic listening test (NVDLT).
• To assess the efficacy of NVDLT in differentiating various dementia subtypes from healthy controls.
• To provide a culturally adaptable tool for assessing central hearing in neurodegenerative diseases.

Main Methods:

• Administered NVDLT to patients with Alzheimer's disease, primary progressive aphasia variants, frontotemporal dementia, and healthy controls.
• Utilized universally familiar non-verbal sounds presented dichotically.
• Adjusted for peripheral hearing, age, sex, and Mini-Mental State Examination scores in analyses.

Main Results:

• All patient groups performed significantly worse on NVDLT compared to healthy controls.
• NVDLT demonstrated high discriminative ability between patients and controls (AUC=0.93).
• Exceptional performance was noted in differentiating Alzheimer's disease (AUC=0.99) and logopenic variant primary progressive aphasia (AUC=1.0) from controls.

Conclusions:

• NVDLT is a sensitive tool for detecting dementia, especially in Alzheimer's-related syndromes.
• Assessing central hearing is crucial in neurodegenerative disease diagnosis.
• The NVDLT offers a promising, culturally adaptable method for dementia screening.